Xtant Medical Holdings, Inc.
XTNT
$0.33
$0.00-0.39%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 23.03M | 20.88M | 32.36M | 33.26M | 35.41M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.03M | 20.88M | 32.36M | 33.26M | 35.41M |
| Cost of Revenue | 9.70M | 8.91M | 14.60M | 11.26M | 11.13M |
| Gross Profit | 13.33M | 11.97M | 17.75M | 21.99M | 24.28M |
| SG&A Expenses | 16.80M | 14.46M | 18.24M | 18.82M | 19.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.20M | 23.81M | 33.30M | 30.71M | 30.79M |
| Operating Income | -4.17M | -2.92M | -944.00K | 2.54M | 4.62M |
| Income Before Tax | -9.34M | -3.06M | 1.60M | 1.57M | 3.81M |
| Income Tax Expenses | 73.00K | 27.00K | 1.54M | 257.00K | 255.00K |
| Earnings from Continuing Operations | -9.41M | -3.09M | 57.00K | 1.31M | 3.55M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.41M | -3.09M | 57.00K | 1.31M | 3.55M |
| EBIT | -4.17M | -2.92M | -944.00K | 2.54M | 4.62M |
| EBITDA | -3.66M | -2.39M | 875.00K | 3.70M | 5.79M |
| EPS Basic | -0.07 | -0.02 | 0.00 | 0.01 | 0.03 |
| Normalized Basic EPS | -0.04 | -0.01 | -0.01 | 0.01 | 0.02 |
| EPS Diluted | -0.07 | -0.02 | 0.00 | 0.01 | 0.02 |
| Normalized Diluted EPS | -0.04 | -0.01 | -0.01 | 0.01 | 0.02 |
| Average Basic Shares Outstanding | 140.26M | 140.06M | 139.83M | 139.71M | 139.31M |
| Average Diluted Shares Outstanding | 140.26M | 140.06M | 150.46M | 150.38M | 148.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |